Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners.

Liu Y, Woodward A, Zhu H, Andrus T, McNevin J, Lee J, Mullins JI, Corey L, McElrath MJ, Zhu T.

J Virol. 2009 Oct;83(20):10821-9. doi: 10.1128/JVI.00839-09. Epub 2009 Aug 12.

2.

Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals.

Zhu T, Corey L, Hwangbo Y, Lee JM, Learn GH, Mullins JI, McElrath MJ.

J Virol. 2003 Jun;77(11):6108-16.

3.

HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand.

Sriwanthana B, Hodge T, Mastro TD, Dezzutti CS, Bond K, Stephens HA, Kostrikis LG, Limpakarnjanarat K, Young NL, Qari SH, Lal RB, Chandanayingyong D, McNicholl JM.

AIDS Res Hum Retroviruses. 2001 May 20;17(8):719-34.

PMID:
11429112
4.

Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

Murakoshi H, Akahoshi T, Koyanagi M, Chikata T, Naruto T, Maruyama R, Tamura Y, Ishizuka N, Gatanaga H, Oka S, Takiguchi M.

J Virol. 2015 May;89(10):5330-9. doi: 10.1128/JVI.00020-15. Epub 2015 Mar 4.

5.

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.

Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T, et al.

Nat Med. 1995 Jan;1(1):59-64. Erratum in: Nat Med 1995 Jun;1(6):598.

PMID:
7584954
6.

Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.

Betts MR, Krowka JF, Kepler TB, Davidian M, Christopherson C, Kwok S, Louie L, Eron J, Sheppard H, Frelinger JA.

AIDS Res Hum Retroviruses. 1999 Sep 1;15(13):1219-28.

PMID:
10480635
7.

Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India.

Pallikkuth S, Wanchu A, Bhatnagar A, Sachdeva RK, Sharma M.

Clin Vaccine Immunol. 2007 Sep;14(9):1196-202. Erratum in: Clin Vaccine Immunol. 2008 Sep;15(9):1494.

8.

Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.

Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E.

J Clin Invest. 1994 Mar;93(3):1293-7.

9.

Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.

Payne RP, Kløverpris H, Sacha JB, Brumme Z, Brumme C, Buus S, Sims S, Hickling S, Riddell L, Chen F, Luzzi G, Edwards A, Phillips R, Prado JG, Goulder PJ.

J Virol. 2010 Oct;84(20):10543-57. doi: 10.1128/JVI.00793-10. Epub 2010 Aug 4.

10.
11.

Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.

Setiawan LC, Gijsbers EF, van Nuenen AC, Kootstra NA.

J Gen Virol. 2015 Aug;96(8):2372-80. doi: 10.1099/vir.0.000148. Epub 2015 Apr 14.

PMID:
25872744
12.

Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons.

Schmechel SC, Russell N, Hladik F, Lang J, Wilson A, Ha R, Desbien A, McElrath MJ.

Immunol Lett. 2001 Nov 1;79(1-2):21-7.

PMID:
11595286
13.

HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.

Zhai S, Zhuang Y, Song Y, Li S, Huang D, Kang W, Li X, Liao Q, Liu Y, Zhao Z, Lu Y, Sun Y.

Curr HIV Res. 2008 Jun;6(4):335-50.

PMID:
18691032
14.

De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.

Allen TM, Yu XG, Kalife ET, Reyor LL, Lichterfeld M, John M, Cheng M, Allgaier RL, Mui S, Frahm N, Alter G, Brown NV, Johnston MN, Rosenberg ES, Mallal SA, Brander C, Walker BD, Altfeld M.

J Virol. 2005 Oct;79(20):12952-60.

15.

Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.

Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ.

N Engl J Med. 1997 Oct 30;337(18):1267-74.

16.

Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.

Koziel MJ, Walker BD.

Springer Semin Immunopathol. 1997;19(1):69-83. Review.

PMID:
9266632
17.

Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus.

Nehete PN, Lewis DE, Tang DN, Pollack MS, Sastry KJ.

Viral Immunol. 1998;11(3):119-29. Erratum in: Viral Immunol 1999;12(1):89.

PMID:
9918403
18.

Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner.

Promadej N, Costello C, Wernett MM, Kulkarni PS, Robison VA, Nelson KE, Hodge TW, Suriyanon V, Duerr A, McNicholl JM.

J Infect Dis. 2003 Apr 1;187(7):1053-63. Epub 2003 Mar 19.

PMID:
12660919
19.

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.

Kelleher AD, Long C, Holmes EC, Allen RL, Wilson J, Conlon C, Workman C, Shaunak S, Olson K, Goulder P, Brander C, Ogg G, Sullivan JS, Dyer W, Jones I, McMichael AJ, Rowland-Jones S, Phillips RE.

J Exp Med. 2001 Feb 5;193(3):375-86.

20.

Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.

Hay CM, Ruhl DJ, Basgoz NO, Wilson CC, Billingsley JM, DePasquale MP, D'Aquila RT, Wolinsky SM, Crawford JM, Montefiori DC, Walker BD.

J Virol. 1999 Jul;73(7):5509-19.

Supplemental Content

Support Center